Baird Starts Intellia Therapeutics (NTLA) at Neutral
Tweet
Share
E-mailGet Alerts NTLA Hot Sheet
Price: $20.02 --0%
Rating Summary:
27 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 1
Rating Summary:
27 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 1
Join SI Premium – FREE
Baird analyst Jack Allen initiates coverage on Intellia Therapeutics (NASDAQ: NTLA) with a Neutral rating and a price target of $58.00.
For an analyst ratings summary and ratings history on Intellia Therapeutics click here. For more ratings news on Intellia Therapeutics click here.
Shares of Intellia Therapeutics closed at $42.86 yesterday.
You May Also Be Interested In
- DA Davidson Starts Napco Security Technologies, Inc. (NSSC) at Buy
- Scotiabank Starts Tenable (TENB) at Sector Perform
- Stifel Upgrades LeMaitre Vascular (LMAT) to Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
